Business Description
Spineguard
ISIN : FR0011464452
Total Employee Number:
15Compare
Compare
Traded in other countries / regions
ALSGD.France6W5.Germany IPO Date
2021-02-10Description
Spineguard is engaged in the design and production of medical instruments used for spinal surgeries. It is deploying its proprietary radiation-free real time sensing technology DSG (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. It designs, develops and markets medical devices embedding its technology. The group is developing DSG digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and smart drills. SpineGuard is extending the applications of its DSG technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.18 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -1.09 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.32 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -29.6 | |||||
3-Year EBITDA Growth Rate | 18.4 | |||||
3-Year EPS without NRI Growth Rate | 24.2 | |||||
3-Year FCF Growth Rate | 31.1 | |||||
3-Year Book Growth Rate | -22.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 9.27 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.39 | |||||
9-Day RSI | 43.14 | |||||
14-Day RSI | 42.8 | |||||
3-1 Month Momentum % | -22.21 | |||||
6-1 Month Momentum % | -25.2 | |||||
12-1 Month Momentum % | -25.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.38 | |||||
Cash Ratio | 0.86 | |||||
Days Inventory | 359.94 | |||||
Days Sales Outstanding | 70.69 | |||||
Days Payable | 546.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.7 | |||||
Shareholder Yield % | -9.75 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.87 | |||||
Operating Margin % | -44.21 | |||||
Net Margin % | -55.02 | |||||
EBITDA Margin % | -35.69 | |||||
FCF Margin % | -30.77 | |||||
OCF Margin % | -27.71 | |||||
ROE % | -45.39 | |||||
ROA % | -24.83 | |||||
ROIC % | -25.51 | |||||
3-Year ROIIC % | 11.04 | |||||
ROC (Joel Greenblatt) % | -190.24 | |||||
ROCE % | -30.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.46 | |||||
PB Ratio | 1.29 | |||||
Price-to-Tangible-Book | 5.79 | |||||
EV-to-EBIT | -4.72 | |||||
EV-to-EBITDA | -5.93 | |||||
EV-to-Revenue | 2.12 | |||||
EV-to-FCF | -6.77 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Median-PS-Value | 0.83 | |||||
| Price-to-Net-Current-Asset-Value | 5.79 | |||||
Earnings Yield (Greenblatt) % | -21.18 | |||||
FCF Yield % | -14.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Spineguard Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.757 | ||
| EPS (TTM) (€) | -0.03 | ||
| Beta | 0.0704 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.24 | ||
| Volatility % | 84.46 | ||
| 14-Day RSI | 42.8 | ||
| 14-Day ATR (€) | 0.002468 | ||
| 20-Day SMA (€) | 0.060585 | ||
| 12-1 Month Momentum % | -25.12 | ||
| 52-Week Range (€) | 0.054261 - 0.246821 | ||
| Shares Outstanding (Mil) | 96.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Spineguard Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Spineguard Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Spineguard Frequently Asked Questions
What is Spineguard(FRA:6W5)'s stock price today?
The current price of FRA:6W5 is €0.06. The 52 week high of FRA:6W5 is €0.25 and 52 week low is €0.05.
When is next earnings date of Spineguard(FRA:6W5)?
The next earnings date of Spineguard(FRA:6W5) is .
Does Spineguard(FRA:6W5) pay dividends? If so, how much?
Spineguard(FRA:6W5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Spineguard
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers